Balloon stent after uterine surgery may reduce scarring

NCT ID NCT07032506

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether placing a small balloon in the uterus for 7-10 days after septum removal surgery can prevent internal scar tissue (adhesions). 320 women will be randomly assigned to receive the balloon plus hormones or hormones alone. The main goal is to see if the balloon lowers the rate of adhesion formation.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
intrauterine pediatric foley catheter balloon
What this could lead to
If it works, this could point toward a simple way to reduce scar tissue after uterine surgery, potentially improving fertility outcomes.
What could go wrong
This is a relatively small, early-stage trial. The balloon may cause discomfort or infection, and it is not yet clear if it will actually prevent adhesions better than standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRAUTERINE ADHESION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Arkansas Fertility & Gynecology

    NOT_YET_RECRUITING

    Little Rock, Arkansas, 72205-0000, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University Hospitals

    NOT_YET_RECRUITING

    Cleveland, Ohio, 44195, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Weill Cornell Medicine

    RECRUITING

    New York, New York, 10021, United States

    Contact

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.